Skip to content

Efficacy and Safety of Color-Doppler Ultrasound Versus Two-dimensional Ultrasound in Reducing Bleeding During Single-tract (18 Fr) Percutaneous Nephrolithotomy: A Prospective–Retrospective Controlled Study

Clinical study on color Doppler flow imaging in reducing bleeding during percutaneous nephrolithotomy surgery - CD2UBP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114024
Enrollment
Unknown
Registered
2025-12-05
Start date
2024-01-07
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney stone (nephrolithiasis) requiring percutaneous nephrolithotomy

Interventions

CDFI Group(Color-Doppler-guided cohort):NA
2D-US Group(Conventional 2D ultrasound cohort):NA

Sponsors

The First Affiliated Hospital of Guangxi Medical University – Hechi People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–70 years, either sex. 2. Renal pelvic and/or calyceal stones = 2 cm or staghorn stones confirmed by CT or KUB. 3. Scheduled to undergo first-time, single-tract (18 Fr) percutaneous nephrolithotomy (PCNL). 4. ASA class = III with no severe cardiac, hepatic, renal or coagulation disorder. 5. Willing to participate: signed informed consent (prospective cohort) or agreed to medical-record use (retrospective cohort).

Exclusion criteria

Exclusion criteria: 1. Previous open or percutaneous renal surgery on the same side. 2. Coagulopathy (INR > 1.5 or platelets 180 mmHg or DBP > 110 mmHg) or ASA = IV. 4. Renal malformation (ectopic, horseshoe, PUJ obstruction, etc.). 5. Pregnancy or lactation. 6. Co-existing ipsilateral renal tumor, active urinary tract infection, or pyonephrosis. 7. Refusal to provide informed consent or inability to comply with post-operative follow-up.

Design outcomes

Primary

MeasureTime frame
Intra-operative blood loss;24-hour post-operative haemoglobin drop;

Secondary

MeasureTime frame
Blood transfusion rate;Super-selective renal arterial embolisation rate;Perirenal haematoma incidence;

Countries

China

Contacts

Public ContactXianyong Yan

Hechi People’s Hospital ( affiliated to The First Affiliated Hospital of Guangxi Medical University ),

wy1930yxy@163.com+86 150 7838 1195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 28, 2026